KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $3.0 million.

  • AbbVie's Change in Acquisitions & Divestments fell 9940.83% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.0 million, marking a year-over-year decrease of 8471.7%. This contributed to the annual value of $555.0 million for FY2024, which is 90909.09% up from last year.
  • AbbVie's Change in Acquisitions & Divestments amounted to $3.0 million in Q3 2025, which was down 9940.83% from $7.0 million recorded in Q2 2025.
  • AbbVie's 5-year Change in Acquisitions & Divestments high stood at $1.4 billion for Q3 2022, and its period low was $3.0 million during Q2 2024.
  • Over the past 5 years, AbbVie's median Change in Acquisitions & Divestments value was $14.0 million (recorded in 2023), while the average stood at $120.0 million.
  • In the last 5 years, AbbVie's Change in Acquisitions & Divestments tumbled by 9964.54% in 2023 and then soared by 1004000.0% in 2024.
  • Quarter analysis of 5 years shows AbbVie's Change in Acquisitions & Divestments stood at $10.0 million in 2021, then soared by 600.0% to $70.0 million in 2022, then tumbled by 80.0% to $14.0 million in 2023, then soared by 178.57% to $39.0 million in 2024, then tumbled by 92.31% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $7.0 million for Q2 2025, and $32.0 million during Q1 2025.